Call 855-808-4530 or email [email protected] to receive your discount on a new subscription.
Features
Arbitration/NFL Agent Contracts<br>Copyright Exemption/Subject-Matter Jurisdiction<br>Sampling/Copyright Infringement<br>Trademark Infringement/TV-Reality Series
Features
COPYRIGHT DAMAGES/CLAIM PRECLUSION<br>LIVE PERFORMANCES/CLAIMS BY ARTIST
Hollywood had its eyes on the California Supreme Court last month when arguments were heard in a case that could shake up the way personal managers and their fame-hungry clients conduct business. The case has the entertainment world all atwitter because the outcome will have a major impact on the complex interplay between personal managers, talent agents and entertainers.
The U.S. District Court for the Southern District of New York dismissed state-law claims brought over the TV broadcast of a 37-second clip of plaintiff Jonathan E. Smith, an animal trainer, being attacked by orca whales at Sea World and a segment of Smith discussing the attack in a later interview.
The RIAA has filed thousands of legal actions since its campaign against unauthorized file sharers began in 2003. For the past two years, Holme Roberts & Owen (HRO), based in Denver, CO, has served as national coordinating counsel for these cases. HRO partner Richard L. Gabriel, the record industry's lead counsel in its national campaign, gave an update on the industry's legal efforts against file sharing in a discussion at his office with <i>Entertainment Law & Finance</i> Editor-in-Chief Stan Soocher.
Wire services are reporting that Merck & Co. has agreed to pay close to $5 billion to settle claims that its Vioxx painkiller caused heart attacks and strokes.
Wire services are reporting that Merck & Co. has agreed to pay close to $5 billion to settle claims that its Vioxx painkiller caused heart attacks and strokes.
Patent lawyers started breathing again on Oct. 31, as the specter of new patent rules was chased away ' at least for a little while ' by a Virginia court. U.S. District Judge James Cacheris granted pharmaceutical giant GlaxoSmithKline's motion for a preliminary injunction blocking the U.S. Patent and Trademark Office from implementing rules set to go into effect on Nov. 1.
Patent lawyers started breathing again on Oct. 31, as the specter of new patent rules was chased away ' at least for a little while ' by a Virginia court. U.S. District Judge James Cacheris granted pharmaceutical giant GlaxoSmithKline's motion for a preliminary injunction blocking the U.S. Patent and Trademark Office from implementing rules set to go into effect on Nov. 1.